LUCARINI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 2.251
EU - Europa 1.655
AS - Asia 303
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 4.213
Nazione #
US - Stati Uniti d'America 2.247
PL - Polonia 858
IT - Italia 216
IE - Irlanda 180
SE - Svezia 172
HK - Hong Kong 100
CN - Cina 72
VN - Vietnam 60
DE - Germania 56
UA - Ucraina 44
JO - Giordania 32
CH - Svizzera 31
GB - Regno Unito 28
FI - Finlandia 23
RU - Federazione Russa 18
SG - Singapore 13
IN - India 10
BE - Belgio 8
FR - Francia 8
ES - Italia 7
KR - Corea 5
CA - Canada 4
NL - Olanda 4
TR - Turchia 4
IR - Iran 3
ID - Indonesia 2
JP - Giappone 2
SC - Seychelles 2
BR - Brasile 1
EU - Europa 1
GR - Grecia 1
PT - Portogallo 1
Totale 4.213
Città #
Warsaw 858
Fairfield 380
Chandler 204
Woodbridge 195
Ashburn 187
Dublin 178
Houston 156
Seattle 140
Wilmington 139
Cambridge 125
Ann Arbor 79
Florence 75
Hong Kong 64
Altamura 61
Lawrence 61
Dong Ket 58
Jacksonville 58
Princeton 48
Beijing 47
Bern 30
Boardman 30
Boston 27
New York 26
Buffalo 21
Medford 20
San Diego 20
Kent 19
Falls Church 17
Moscow 16
Norwalk 11
Los Angeles 9
Shanghai 9
Phoenix 8
Rome 8
West Jordan 8
Barcelona 7
Brussels 7
Dearborn 7
Singapore 7
Andover 5
Hillsboro 5
London 5
Sesto Fiorentino 5
Bremen 4
Chennai 4
Nanjing 4
Toronto 4
Chicago 3
Frankfurt Am Main 3
Milan 3
Misano Adriatico 3
Pune 3
Redwood City 3
Siena 3
Tappahannock 3
Tehran 3
Yeongdeungpo-gu 3
Alessandria 2
Anguillara Sabazia 2
Antakya 2
Asagayakita 2
Castelliri 2
Chengdu 2
Chiswick 2
Fremont 2
Fuzhou 2
Grevenbroich 2
Izmir 2
Kowloon 2
Malmo 2
Messina 2
Naples 2
Nürnberg 2
Prato 2
Seoul 2
Surabaya 2
Venice 2
Verona 2
Acton 1
Aversa 1
Bologna 1
Calenzano 1
Dubendorf 1
Encino 1
Evanston 1
Gavirate 1
Genova 1
Guangzhou 1
Hangzhou 1
Hanover 1
Kunming 1
Lucca 1
Mykolayiv 1
Nagold 1
Neuilly-sur-seine 1
Nocera Superiore 1
Paluzza 1
Pistoia 1
Poggio a Caiano 1
Portland 1
Totale 3.550
Nome #
Cyclooxygenase-2 and Inflammation Mediators Have a Crucial Role in Reflux-Related Esophageal Histological Changes and Barrett's Esophagus 238
CYTOKINE GENE EXPRESSION AND PRODUCTION BY HUMAN LPS-STIMULATED MONONUCLEAR CELLS ARE INHIBITED BY SULFATED HEPARIN-LIKE SEMI-SYNTHETIC DERIVATIVES. 237
PLASMATIC CARBONIC ANHYDRASE IX AS A DIAGNOSTIC MARKER FOR CLEAR CELL RENAL CELL CARCINOMA 228
The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response Pathways. 219
A homozygous COL6A2 intron mutation causes in-frame triple-helical deletion and nonsense-mediated mRNA decay in a patient with Ullrich congenital muscular dystrophy. 214
Different Antioxidant Efficacy of Two MnII-Containing Superoxide Anion Scavengers on Hypoxia/Reoxygenation-Exposed Cardiac Muscle Cells 171
A Selective Histamine H4 Receptor Antagonist, JNJ7777120, Is Protective in a Rat Model of Transient Cerebral Ischemia 153
Role of histamine H3 receptor antagonists on intraocular pressure reduction in rabbit models of transient ocular hypertension and glaucoma 141
Role of TGFBR1 and TGFBR2 genetic variants in Marfan syndrome 130
Effect of mediterranean diet enriched in high quality extra virgin olive oil on oxidative stress, inflammation and gut microbiota in obese and normal weight adult subjects 124
HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway 121
1,3-Oxazole-based selective picomolar inhibitors of cytosolic human carbonic anhydrase II alleviate ocular hypertension in rabbits: Potency is supported by X-ray crystallography of two leads 120
Poly(ADP-ribose) polymerase inhibition with HYDAMTIQ reduces allergen-induced asthma-like reaction, bronchial hyper-reactivity and airway remodelling. 119
2-Benzylpiperazine: a new scaffold for potent human Carbonic Anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in vivo activity for a new class of intraocular pressure lowering agents. 110
Protection from Cigarette Smoke-Induced Lung Dysfunction and Damage by H2 Relaxin (Serelaxin) 107
Structural insights on carbonic anhydrase inhibitory action, isoform selectivity, and potency of sulfonamides and coumarins incorporating arylsulfonylureido groups. 105
FBN1 mutation screening of patients with Marfan syndrome and related disorders: detection of 46 novel FBN1 mutations. 99
Role of histamine H4 receptor ligands in bleomycin-induced pulmonary fibrosis 95
A single heterozygous nucleotide substitution displays two different altered mechanisms in the FBN1 gene of five Italian Marfan patients 94
Histamine H4 receptor agonist-induced relief from painful peripheral neuropathy is mediated by inhibition of spinal neuroinflammation and oxidative stress 94
Histamine H4 receptor activation alleviates neuropathic pain through differential regulation of ERK, JNK and P38 MAPK phosphorylation 94
Fibroblast autofluorescence in connective tissue disorders: a future tool for clinical and differential diagnosis? 91
Prevention of bleomycin-induced lung inflammation and fibrosis in mice by naproxen and JNJ7777120 treatment 85
A new low molecular weight, Mn(II)-containing scavenger of superoxide anion protects cardiac muscle cells from hypoxia/reoxygenation injury. 84
Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy 81
Effects of a selective histamine H4r antagonist on inflammation in a model of carrageenan-induced pleurisy in the rat 78
Dominant and recessive COL6A1 mutations in Ullrich scleroatonic muscular dystrophy 71
Is ectopia lentis in some cases a mild phenotypic expression of Marfan syndrome? Need for a long-term follow-up. 68
Erratum: The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways (Oncology Research 25:9 (1441-1451) DOI: 10.3727/096504017X14926854178616) 68
2-(2-Hydroxyethyl)piperazine derivatives as potent human carbonic anhydrase inhibitors: Synthesis, enzyme inhibition, computational studies and antiglaucoma activity 66
D-Tagatose Feeding Reduces the Risk of Sugar-Induced Exacerbation of Myocardial I/R Injury When Compared to Its Isomer Fructose 63
COL6A1 genomic deletions in Bethlem myopathy and Ullrich muscular dystrophy 60
Ullrich myopathy phenotype with secondary ColVI defect identified by confocal imaging and electron microscopy analysis. 59
Effects of new nsaid-cai hybrid compounds in inflammation and lung fibrosis 58
Targeting the RNA-Binding Protein HuR Alleviates Neuroinflammation in Experimental Autoimmune Encephalomyelitis: Potential Therapy for Multiple Sclerosis 58
Sulfonamide Inhibitors of Human Carbonic Anhydrases Designed through a Three-Tails Approach: Improving Ligand/Isoform Matching and Selectivity of Action 56
Characterization of behavioral phenotypes in histamine H4-receptor knockout mice 49
HISTAMINE H4 RECEPTOR ACTIVATION INDUCES ANTINOCICEPTION IN A NEUROPATHIC PAIN MODEL 40
One-Pot Procedure for the Synthesis of Asymmetric Substituted Ureido Benzene Sulfonamides as Effective Inhibitors of Carbonic Anhydrase Enzymes 34
Discovery of Potent Dual-Tailed Benzenesulfonamide Inhibitors of Human Carbonic Anhydrases Implicated in Glaucoma and in Vivo Profiling of Their Intraocular Pressure-Lowering Action 31
The histamine h4 receptor participates in the anti-neuropathic effect of the adenosine a3 receptor agonist ib-meca: Role of cd4+ t cells 28
NCX 470 Restores Ocular Hemodynamics and Retinal Cell Physiology After ET-1-Induced Ischemia/Reperfusion Injury of Optic Nerve and Retina in Rabbits 22
Identification of Bivalent Ligands with Melatonin Receptor Agonist and Fatty Acid Amide Hydrolase (FAAH) Inhibitory Activity That Exhibit Ocular Hypotensive Effect in the Rabbit 14
In vitro cell growth inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on human tumor cell lines with defective DNA damage response pathways 8
NCX 470 Exerts Retinal Cell Protection and Enhances Ophthalmic Artery Blood Flow After Ischemia/Reperfusion Injury of Optic Nerve Head and Retina 7
Novel Carbonic Anhydrase Inhibitors with Dual-Tail Core Sulfonamide Show Potent and Lasting Effects for Glaucoma Therapy 6
Totale 4.298
Categoria #
all - tutte 12.783
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.783


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019109 0 0 0 0 0 0 0 0 0 0 0 109
2019/20201.030 70 78 29 88 121 117 114 124 106 74 91 18
2020/2021756 46 60 24 81 42 83 39 47 66 150 36 82
2021/2022344 13 9 26 14 13 23 33 27 15 26 54 91
2022/2023937 84 203 47 71 62 136 108 59 101 8 19 39
2023/2024360 21 36 47 19 21 56 16 70 11 31 27 5
Totale 4.298